Techcyte and Cytobay Partner to Create Non-Invasive Digital Diagnostic Test for Bladder Cancer

Bladder cancer is one of the most common cancers and has a high recurrence rate.  After successful treatment, it is recommended that survivors be tested every three to six months for the first two years, every six to twelve months for years three to four, and then yearly from then on. This invasive test for [...]